Author

Ashley V. DiMarco

Duke UniversityORCID 0000-0001-7352-9093Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

Brock J. McKinneyiD· 1 shared Feinan WuiD· 1 shared James V. AlvareziD· 1 shared Jessica N. BecerraiD· 1 shared Matthew FitzgibboniD· 1 shared Nina Marie G. GarciaiD· 1 shared Sharan SrinivasaniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Brock J. McKinneyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer Research CommunicationsPeer-reviewedMay 1, 2025

APOBEC3 activity promotes the survival and evolution of drug-tolerant persister cells during acquired resistance to EGFR inhibitors in lung cancer

Nina Marie G. Garcia, Jessica N. Becerra, Sharan Srinivasan…·James V. Alvarez

This study shows APOBEC3 activity supports drug-tolerant persister cells in EGFR inhibitor-resistant lung cancer by promoting transdifferentiation and mutation acquisition.

23 citationstop 1%

humanDNA methylation

𝕏 PostBluesky